Drug Trial Radar · NCT04119843
Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
87
Actual
Start
Feb 19, 2020
Primary completion
Feb 17, 2023
Study completion Feb 17, 2023
Sponsor
- Lead sponsor
- Ascelia Pharma ABIndustry
- Sponsor type
- Industry
- First posted
- Oct 8, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The overall objective of this study is to evaluate the safety and diagnostic efficacy of Mangoral in liver MRI in participants with known or suspected focal liver lesions and severe renal impairment. The diagnostic efficacy of Mangoral will be assessed in terms of visualization of detected focal liver lesions in combined MRI (CMRI: combined Mangoral-enhanced and unenhanced MRI) compared to unenhanced MRI.
Conditions
- Known or Suspected Focal Liver Lesions
- Severe Renal Impairment
Interventions
MangoralDrug
800 mg manganese chloride \[II\] tetrahydrate, 500 mg L-alanine, and 800 IU vitamin D3
Primary outcomes
What the sponsor says the trial is designed to measure.
- Co-primary Endpoint: Lesion Border Delineation in Combined MRI Compared to Unenhanced MRITime frame: Unenhanced MRI: Baseline Period (Day -1 to Day 0); combined MRI: Baseline Period (Day -1 to Day 0) and 4 hours after mangoral administration on Day 0
- Co-primary Endpoint: Lesion Contrast in Combined MRI Compared to Unenhanced MRITime frame: Unenhanced MRI: Baseline Period (Day -1 to Day 0); combined MRI: Baseline Period (Day -1 to Day 0) and 4 hours after mangoral administration on Day 0
Locations
60 sites in 10 countries. Site status is shown where the registry gives one.
Mayo Clinic - Arizona
Scottsdale, Arizona
University of California at Los Angeles Ronald Reagan Medical Center
Los Angeles, California
Stanford University School of Medicine
Stanford, California
Mayo Clinic - Jacksonville
Jacksonville, Florida
Schiff Center for Liver Diseases
Miami, Florida
University of Kansas Medical Center
Kansas City, Kansas
Johns Hopkins Bayview Medical Center
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Boston University Medical Center
Boston, Massachusetts
Saint Louis University
St Louis, Missouri
Duke University
Durham, North Carolina
PanAmerican Clinical Research LLC
Brownsville, Texas
University of Washington Medical Center
Seattle, Washington
University of Wisconsin - Madison
Madison, Wisconsin
Centro Rossi Body Imaging
Buenos Aires, Argentina
Sanatorio Allende Nueva Córdoba
Córdoba, Argentina
Fundación Intecnus
Bariloche, Río Negro Province, Argentina
Hospital Pablo Tobon Uribe
Medellín, Antioquia, Colombia
Clínica Universitaria Colombia
Bogotá, Cundinamarca, Colombia
Sociedad de Cirugía de Bogotá - Hospital de San José
Bogotá, Cundinamarca, Colombia
Charité - Universitätsmedizin Berlin
Berlin, Germany
Universitätsklinikum Frankfurt Institut für Diagnostische und Interventionelle Radiologie
Frankfurt, Germany
Universitätsmedizin Göttingen
Göttingen, Germany
Städtisches Klinikum KarlsruheDiagnostische und interventionelle Radiologie
Karlsruhe, Germany
Universitättsklinikum Schleswig-Holstein/Campus KielKlinik für Radiologie und Neuroradiologie
Kiel, Germany
Klinik und Poliklinik für Radiologie Klinikum der Universität München LMU Campus
Munich, Germany
Institut für Röntgendiagnostik
Regensburg, Germany
Azienda Ospedaliero-Universitaria di Bologna Policlinico S.Orsola-Malpighi
Bologna, Italy
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
Milan, Italy
Ospedale del Mare
Naples, Italy
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
Naples, Italy
Università Cattolica del Sacro Cuore
Roma, Italy
Azienda Ospedaliero-Universitaria Policlinico Umberto I
Rome, Italy
Ospedale di Belcolle
Viterbo, Italy
Azienda Socio Sanitaria Territoriale (ASST)
Milan, Lombardy, Italy
Panamerican Clinical Research - Cuernavaca Rio Mayo
Cuernavaca, Mexico
Panamerican Clinical Research Mexico
Guadalajara, Mexico
Panamerican Clinical Research - Querétaro Avenida Paseo de la República
Querétaro, Mexico
Szpital Uniwersytecki nr 1 im. Dr A. Jurasza, Wydział Katedra i Zakład Radiologii i Diagnostyki Obrazowej
Bydgoszcz, Poland
Szpital Uniwersytecki w Krakowie Zakład Diagnostyki Obrazowej CUMRiK Ul
Krakow, Poland
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.